...
首页> 外文期刊>Arquivos brasileiros de cardiologia. >Seria a Revasculariza??o Completa Verdadeiramente Superior à ICP apenas da Les?o Culpada em Pacientes que Apresentam Infarto Agudo do Miocárdio com Supradesnivelamento do Segmento ST?
【24h】

Seria a Revasculariza??o Completa Verdadeiramente Superior à ICP apenas da Les?o Culpada em Pacientes que Apresentam Infarto Agudo do Miocárdio com Supradesnivelamento do Segmento ST?

机译:血运重建会真正大于ICP的ICP吗?患者患有急性心肌梗死的患者与ST段调平。

获取原文

摘要

Primary percutaneous coronary intervention (PCI) is a standard therapy for patients with acute ST-segment elevation myocardial infarction (STEMI), and its goal is to restore blood flow to the coronary artery that is judged to be causing the myocardial infarction (known as the culprit artery). In up to half of such patients, major stenoses in one or more coronary arteries that are not responsible for the myocardial infarction (nonculprit lesions) may also be seen during the index angiography.1 Since patients with acute STEMI and multivessel coronary artery disease (CAD) have worse clinical outcomes compared with patients with single-vessel disease, it has been questioned if PCI treatment of all significant nonculprit lesions following primary PCI (complete revascularization) could improve prognosis.
机译:初级经皮冠状动脉干预(PCI)是急性ST段升高心肌梗死患者(Stemi)的标准治疗,其目标是将血流恢复到冠状动脉判断为导致心肌梗塞的冠状动脉(称为罪魁祸首动脉。在此类患者的一半中,在指数血管造影期间也可以在指数血管造影期间在一个或多个冠状动脉中的主要狭窄,因为急性血管造影术期间也可以在急性血管造影术期间看到(CAD冠状动脉疾病(CAD) )与单血管疾病的患者相比,临床结果较差,如果PCI治疗原发性PCI(完全血运重建)后的所有显着的非额外病变可以改善预后。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号